Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model
Authors
Keywords
Mouse models, Polymerase chain reaction, Heart failure, Cardiovascular physiology, Blood pressure, Heart, Sequence motif analysis, CRISPR
Journal
PLoS One
Volume 11, Issue 12, Pages e0168486
Publisher
Public Library of Science (PLoS)
Online
2016-12-20
DOI
10.1371/journal.pone.0168486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic heart failure: Ca 2+ , catabolism, and catastrophic cell death
- (2016) Geoffrey W. Cho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment
- (2015) Przemek A. Gorski et al. Cell Metabolism
- The impact of CRISPR–Cas9 on target identification and validation
- (2015) Jonathan D. Moore DRUG DISCOVERY TODAY
- CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes
- (2015) Hua Zhong et al. Scientific Reports
- One-step generation of knockout pigs by zygote injection of CRISPR/Cas system
- (2014) Tang Hai et al. CELL RESEARCH
- Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes
- (2014) Shuo-Ting Yen et al. DEVELOPMENTAL BIOLOGY
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Generation of gene-modified mice via Cas9/RNA-mediated gene targeting
- (2013) Bin Shen et al. CELL RESEARCH
- Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos
- (2013) Nannan Chang et al. CELL RESEARCH
- Heart Disease and Stroke Statistics—2014 Update
- (2013) Alan S. Go et al. CIRCULATION
- Calcium cycling proteins and heart failure: mechanisms and therapeutics
- (2013) Andrew R. Marks JOURNAL OF CLINICAL INVESTIGATION
- Heritable gene targeting in the mouse and rat using a CRISPR-Cas system
- (2013) Dali Li et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca waves or Ca currents?
- (2012) Zhenghang Zhao et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
- (2012) Evangelia G. Kranias et al. CIRCULATION RESEARCH
- SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure
- (2011) Alexander R. Lyon et al. Circulation-Arrhythmia and Electrophysiology
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- Acute Heart Failure Syndromes
- (2009) Mihai Gheorghiade et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals
- (2008) M J Byrne et al. GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started